Philip Went
Impact in
- Oncology top 1%
- Cancer Cells and Metastasis
- Viral-associated cancers and disorders
- CAR-T cell therapy research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 33
- Oncology 22
- HER2/EGFR in Cancer Research 5
- Viral-associated cancers and disorders 5
- Co-authors
- Stephan Dirnhofer (32 shared papers)Alexandar Tzankov (32 shared papers)Stefano Pileri (23 shared papers)Guido Sauter (6 shared papers)Alessandro Lugli (7 shared papers)Martina Mirlacher (3 shared papers)Marcel Bundi (2 shared papers)Patrick A. Baeuerle (3 shared papers)
- Journals
- Journal of Clinical Pathology (6 papers)Human Pathology (6 papers)Modern Pathology (5 papers)Journal of Clinical Oncology (3 papers)European Journal of Surgical Oncology (3 papers)
- Partner nations
- SwitzerlandItalyAustria
In The Last Decade
Philip Went
84 papers receiving 4.6k citations
Philip Went's Hit Papers
Peers
Comparison fields: 5 of 106
- Oncology 2.0k
- Pathology and Forensic Medicine 1.2k
- Immunology 918
- Cancer Research 520
- Genetics 356
Countries citing papers authored by Philip Went
This map shows the geographic impact of Philip Went's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Went with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Went more than expected).
Fields of papers citing papers by Philip Went
This network shows the impact of papers produced by Philip Went. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Went. The network helps show where Philip Went may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip Went, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Frequent EpCam protein expression in human carcinomas Hit paper breakdown → | 2004 | 675 |
| 2 | Nuclear signalling by tumour-associated antigen EpCAM Hit paper breakdown → | 2009 | 568 |
| 3 | 2008 | 321 | |
| 4 | 2006 | 316 | |
| 5 | 2006 | 275 | |
| 6 | 2011 | 232 | |
| 7 | 2007 | 212 | |
| 8 | 2004 | 206 | |
| 9 | 2004 | 175 | |
| 10 | 2006 | 170 | |
| 11 | 2009 | 101 | |
| 12 | 2003 | 94 | |
| 13 | 2009 | 78 | |
| 14 | 2004 | 77 | |
| 15 | 2005 | 77 | |
| 16 | 2005 | 68 | |
| 17 | 2009 | 67 | |
| 18 | 2003 | 50 | |
| 19 | 2010 | 50 | |
| 20 | 2004 | 46 |
About Philip Went
Philip Went is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Pulmonary and Respiratory Medicine and Immunology, having authored 86 papers that have together received 4.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (33 papers), Chronic Lymphocytic Leukemia Research (10 papers), T-cell and Retrovirus Studies (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), HER2/EGFR in Cancer Research (5 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Viral-associated cancers and disorders (5 papers). The work is most often cited by research in Oncology (2.0k citations), Pathology and Forensic Medicine (1.2k citations), Immunology (918 citations), Cancer Research (520 citations) and Genetics (356 citations). Philip Went has collaborated with scholars based in Switzerland, Italy and Austria. Frequent co-authors include Stephan Dirnhofer, Alexandar Tzankov, Stefano Pileri, Guido Sauter, Alessandro Lugli, Martina Mirlacher, Marcel Bundi, Patrick A. Baeuerle, Sandra Meier and S Dirnhofer. Their work appears in journals such as Journal of Clinical Pathology, Human Pathology, Modern Pathology, Journal of Clinical Oncology and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.